50.1% men)
The data on GLP-1 withdrawal is sobering
Which medicines are covered The PAP only covers a specific list of Novo Nordisk registered trademark medicines, which currently includes certain GLP-1 medications (Ozempic, Rybelsus and Xultophy), insulin products (Fiasp, Novolin R, Novolin N and Novolin 70/30, NovoLog Vial, NovoLog PenFill and Flexpen, NovoLog Mix, Tresiba), devices (Novopen, NovoFine), and other selected specialty therapies
IV drip therapy suits most individuals, particularly those seeking to replenish hydration, enhance nutrient levels, recover from fatigue, or support their overall wellness
Its weight-loss effects are primarily achieved through several mechanisms, including central appetite regulation via hypothalamic pathways enhancing satiety, delayed gastric emptying that prolongs postprandial fullness, improvement of insulin sensitivity and metabolic homeostasis, and reduction of visceral and hepatic fat depots, which may alleviate respiratory mechanical burden and metabolic stress in OSAS (34)
People are already taking other weight loss medicines